1. Food and Drug Administration (FDA). 2003. Guidance for Industry. Exposure-response relationships–study design, data analysis and regulatory applications. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm072109.pdf. Accessed January 10, 2016.
2. Food and Drug Administration (FDA). 2014. Guidance for Industry. General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm425885.pdf. Accessed January 10, 2016.
3. European Medicines Agency (EMA). 2007. Guideline on the Role of Pharmacokinetics in the Development of medicinal Products in the Paediatric Population. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003066.pdf. Accessed January 10, 2016.
4. Extrapolation of adult data and other data in pediatric drug-development programs;Dunne;Pediatrics,2011
5. Impact of developmental pharmacology on pediatric study design: overcoming the challenges;Kearns;J Allergy Clin Immunol,2000